Latest Breaking News On - Tuyen ong - Page 2 : comparemela.com

Nevakar Announces Formation Of Ophthalmic Company, Vyluma News provided by Share this article Share this article BRIDGEWATER, N.J., May 25, 2021 /PRNewswire/  Nevakar Inc. ( Nevakar ), a privately held biopharmaceutical company, today announces the establishment of Vyluma Inc., a newly formed company with a focus on the development and commercialization of therapies to treat ophthalmic diseases. At inception Vyluma will operate as a wholly owned subsidiary of Nevakar Inc. Vyluma will focus on first-in-class and best-in-class ophthalmic pharmaceutical therapies, with an emphasis on refractive errors. Currently, there are no pharmaceutical treatment options approved for refractive errors such as childhood myopia, presbyopia, night vision disturbance, and hyperopia.  NVK002 is Vyluma s lead product candidate in late Phase III clinical development with readouts anticipated in the fourth quarter of 2022.  If approved, it would be the first pharmaceutical therapy to slow the progr

Houman hemmatiRaula trillo jrMarshall woodworthVyluma incNevakar incNavneet puriFinancial officerChief commercial officerChief medicalChief medical officerTuyen ongRing therapeuticsமார்ஷல் வூட்வொர்த்நாவ்நீட் பூரிநிதி அதிகாரிதலைமை வணிகரீதியானது அதிகாரி